False-Positive Metaiodobenzylguanidine Scan for Neuroblastoma in a Child With Opsoclonus-Myoclonus Syndrome Treated With Adrenocorticotropic Hormone (ACTH)

Abstract

We describe the case of a 2-year-old girl with opsoclonus-myoclonus syndrome treated with chronic adrenocorticotropic hormone (ACTH) in which a metaiodobenzylguanidine scan showed abnormal radiotracer uptake in the left adrenal gland region, interpreted as the site of an occult neuroblastoma. As this finding was not corroborated by previous or subsequent metaiodobenzylguanidine scans or by computed tomography (CT) or magnetic resonance imaging (MRI), we attribute the finding to being a false-positive result from adrenal hyperplasia owing to chronic use of ACTH and not to neuroblastoma. Metaiodobenzylguanidine scintigraphy is an extremely important nuclear medicine examination tool used for the evaluation and staging of pediatric neuroblastoma. We highlight the need for cautious interpretation of metaiodobenzylguanidine as a screening tool for neuroblastoma in patients treated with ACTH. (J Child Neurol 2006;21:606—610; DOI 10.2310/ 7010.2006.00143).

Get full access to this article

View all access options for this article.

References

Lott I. , Kinsbourne M. : Myoclonic encephalopathy of infants. Adv Neurol 1986;43:127—136.

Shapiro B. , Shulkin BL , Hutchinson RJ , et al: Locating neuroblastoma in the opsoclonus-myoclonus syndrome. J Nucl Biol Med 1994;38: 545—555.

Bray PF , Ziter FA , Lahey ME , Myers GG : The coincidence of neuroblastoma and acute cerebellar encephalopathy. Trans Am Neurol Assoc 1969;94:106—109.

Baker ME , Kirks DR , Korobkin M. , et al: The association of neuroblastoma and myoclonic encephalopathy: An imaging approach. Pediatr Radiol 1985;15:184—190.

Koh PS , Raffensperger JG , Berry S. , et al: Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma. J Pediatr 1994;125:712—716.

Wolff M. , Schoning M. , Niemann G. , Krageloh-Mann I: Late detection of neuroblastoma in a patient with prolonged cerebellar ataxia without opsoclonus. Neuropediatrics 2001;32:101—103.

Gelfand MJ , Elgazzar AH , Kriss VM , et al: Iodine-123-MIBG SPECT versus planar imaging in children with neural crest tumors. J Nucl Med 1994;35:1753—1757.

Hoefnagel CA , Voute PA , de Kraker J. , Marcuse HR : Radionuclide diagnosis and therapy of neural crest tumors using iodine-131 metaiodobenzylguanidine. J Nucl Med 1987;28:308—314.

Feine U. , Muller-Schauenburg W. , Treuner J. , Klingebiel T. : Metaiodobenzylguanidine (MIBG) labeled with 123I/131I in neuroblastoma diagnosis and follow-up treatment with a review of the diagnostic results of the International Workshop of Pediatric Oncology held in Rome, September 1986. Med Pediatr Oncol 1987; 15:181—187.

10.

Snyder HM , Evans AE , Raney RB : Pediatric oncology, in Campbell's Urology. Philadelphia , Saunders, 1986, 2265—2276.

11.

Ziegelbaum MM , Kay R. , Rothner AD , Lorig R. : The association of neuroblastoma with myoclonic encephalopathy of infants: The use of magnetic resonance as an imaging modality . J Urol 1988;139:81—82.

12.

Boltshauser E. , Deonna T. , Hirt HR : Myoclonic encephalopathy of infants or ``dancing eyes syndrome.'' Report of 7 cases with long-term follow-up and review of the literature (cases with and without neuroblastoma). Helv Paediatr Acta 1979;34:119—133.

13.

Farrelly C. , Daneman A. , Chan HS , Martin DJ : Occult neuroblastoma presenting with opsomyoclonus: Utility of computed tomography. AJR Am J Roentgenol 1984;142:807—810.

14.

Lumbroso JD , Guermazi F. , Hartmann O. , et al: Meta-iodobenzylguanidine (mIBG) scans in neuroblastoma: Sensitivity and specificity, a review of 115 scans. Prog Clin Biol Res 1988;271:689—705.

15.

International Society of Pediatric Oncology , Italian Society of Radiology and Nuclear Medicine, Italian Society of Biology and Nuclear Medicine, and Associazione Genitori Oncologia Pediatrica. IVth International Workshop in Pediatric Oncology, ``The role of MIBG in therapy, diagnosis, and monitoring of neuroblastoma'' Rome, Italy, September 22 and 23, 1986. Proceedings. Med Pediatr Oncol, 1987;15:226—228.

16.

Leung A. , Shapiro B. , Hattner R. , et al: Specificity of radioiodinated MIBG for neural crest tumors in childhood. J Nucl Med 1997;38:1352— 1357.

17.

Stewart RE , Grossman DM , Shulkin BL , Shapiro B. : Iodine-131 metaiodobenzylguanidine uptake in infantile myofibromatosis. Clin Nucl Med 1989;14:344—346.

18.

Feggi L. , Degli Uberti E. , Pansini GC , et al: Pitfalls in scintigraphic detection of neuroendocrine tumours . Eur J Nucl Med 1992;19:214— 218.

19.

Horne T. , Glaser B. , Krausz Y. , et al: Unusual causes of I-131 metaiodobenzylguanidine uptake in non-neural crest tissue. Clin Nucl Med 1991;16:239—242.

20.

Von Moll L. , McEwan AJ , Shapiro B. , et al: Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma. J Nucl Med 1987;28:979—988.

21.

Dessner DA , DiPietro MA , Shulkin BL : MIBG detection of hepatic neuroblastoma: Correlation with CT, US and surgical findings. Pediatr Radiol 1993;23:276—280.

22.

Burt MG , Allen B. , Conaglen JV : False positive 131I-metaiodobenzylguanidine scan in the postoperative assessment of malignant phaeochromocytoma secondary to medullary hyperplasia. N Z Med J 2002;115:18.

23.

Boersma HH , Wensing JW , Kho TL , et al: Compensatory uptake of I-123 MIBG in the contralateral adrenal gland after removal of a pheochromocytoma. Clin Nucl Med 2002;27:113—116.

24.

Kusher BH : Neuroblastoma: A disease requiring a multitude of imaging studies. J Nucl Med 2004;45:1172—1188.

25.

Olivier P. , Colarinha P. , Fettich J. , et al: Guidelines for radioiodinated MBG scintigraphy in children. Eur J Nucl Med Mol Imaging 2003;30: 39—44.

26.

Liebling MS , Starc TJ , McAlister WH , et al: ACTH induced adrenal enlargement in infants treated for infantile spasms and acute cerebellar encephalopathy. Pediatr Radiol 1993;23:454—456.

27.

Gumbinas M. , Gratz ES , Johnston GS , Schwartz AD : Positive gallium scan in the syndrome of opsoclonus-myoclonus treated with adrenocorticotropic hormone. Cancer 1984;54:815—816.